Sign in

CIK 0001579428 · Large accelerated filer

Axsome Therapeutics, Inc.

Sign in to watch
Ticker
AXSM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
454241907
Phone
(212) 332-3241
Business address
ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
  1. 4 Planned sale Chief Operating Officer sold 10,000 shares at $115.96 ($1,159,600)
  2. 4 Planned sale Chief Operating Officer sold 45,783 shares at an average $114.48 ($5,241,127)
  3. 4 Planned sale Chief Executive Officer sold 62,880 shares at an average $117.08 ($7,361,891)
  4. 4 Open-market buy Director bought 1,575 shares at an average $127.28 ($200,466)
  5. 4 Planned sale Director sold 9,127 shares at $125.07 ($1,141,514)
  6. 4 Planned sale Director sold 13,464 shares at $123.68 ($1,665,228)
  7. 4 Planned sale Director sold 60,000 shares at an average $121.72 ($7,303,400)
  8. 4 Planned sale Director sold 36,694 shares at an average $120.05 ($4,405,216)
  9. 4 Planned sale General Counsel sold 13,514 shares at an average $101.42 ($1,370,647)
  10. 4 Planned sale General Counsel sold 22,500 shares at an average $101.19 ($2,276,850)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Planned sale Chief Operating Officer sold 25,000 shares at $110.44 ($2,761,000)
  15. 4 Derivatives Options or other derivatives
  16. 4 Planned sale Director sold 7,500 shares at an average $104.45 ($783,375)
  17. 4 Planned sale Chief Operating Officer sold 40,673 shares at an average $104.07 ($4,232,636)
  18. 4 Open-market sale Director sold 3,000 shares at $107.49 ($322,473)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 3 of 11 · 211 filings